April 6 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO
* Cipher Pharmaceuticals announces approvals of astion
acquired barrier creams by Health Canada and the Medicines
Evaluation Board
* Says in addition European approval of helioclin pruritus
SD cream (also known as pruridexin) was achieved
* In Canada , Cipher plans to market products through its
internal sales team
* Says company expects to out-license helioclin pruritus sd
cream and helioclin dermatitis SD cream in Europe
Source text for Eikon: ID:nCNWkpHFLa
Further company coverage: CPH.TO
(Bengaluru Newsroom: +1-646-223-8780)